Literature DB >> 21713569

Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism.

Andreza Urba de Quadros1, Daniel Bini, Priscilla Aparecida Tartari Pereira, Estela Glória Moroni, Marta Chagas Monteiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21713569     DOI： 10.1007/s12223-011-0049-6

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


× No keyword cloud information.
  18 in total

1.  Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis.

Authors:  R Deva; R Ciccoli; L Kock; S Nigam
Journal:  FEMS Microbiol Lett       Date:  2001-04-20       Impact factor: 2.742

Review 2.  Mechanism of action of antiinflammatory drugs.

Authors:  J R Vane; R M Botting
Journal:  Int J Tissue React       Date:  1998

3.  Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.

Authors:  M C Noverr; S M Phare; G B Toews; M J Coffey; G B Huffnagle
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 4.  Antifungal agents: mode of action in yeast cells.

Authors:  A J Carrillo-Muñoz; G Giusiano; P A Ezkurra; G Quindós
Journal:  Rev Esp Quimioter       Date:  2006-06       Impact factor: 1.553

5.  Effect of inhibitors of arachidonic acid metabolism on prostaglandin E₂ production by Candida albicans and Candida dubliniensis biofilms.

Authors:  Ruan Ells; Johan L F Kock; Jacobus Albertyn; Gabré Kemp; Carolina H Pohl
Journal:  Med Microbiol Immunol       Date:  2010-09-07       Impact factor: 3.402

6.  Characterization of prostaglandin E2 production by Candida albicans.

Authors:  John R Erb-Downward; Mairi C Noverr
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

7.  The role of laccase in prostaglandin production by Cryptococcus neoformans.

Authors:  John R Erb-Downward; Rachael M Noggle; Peter R Williamson; Gary B Huffnagle
Journal:  Mol Microbiol       Date:  2008-04-11       Impact factor: 3.501

8.  Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro.

Authors:  E M Scott; V N Tariq; R M McCrory
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

9.  Prostaglandin E(2) production by high and low virulent strains of Paracoccidioides brasiliensis.

Authors:  Ana Paula Bordon; Luciane Alarcão Dias-Melicio; Michele Janegitz Acorci; Guilherme Augusto Biondo; Denise Fecchio; Maria Terezinha Serrão Peraçoli; Angela Maria Victoriano Campos de Soares
Journal:  Mycopathologia       Date:  2007-03-15       Impact factor: 2.574

10.  Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Authors:  J A Mitchell; P Akarasereenont; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205
View more
  14 in total

1.  Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms.

Authors:  Rafaelle Fonseca de Matos; Lúcia Carla Vasconcelos Mendonça; Kaira Geiliane da Silva Souza; Adriana Aparecida Durães Fonseca; Elaine Mirla Souza Costa; Marcus Vinicius Dias de Lima; José Maria Dos Santos Vieira; Mioni Thielli Figueiredo Magalhães de Brito; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2016-11-19       Impact factor: 2.099

Review 2.  Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier.

Authors:  Ziyao Peng; Jianguo Tang
Journal:  Front Microbiol       Date:  2022-02-02       Impact factor: 5.640

3.  Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans.

Authors:  E Abdelmegeed; Mona Ibrahim Shaaban
Journal:  J Microbiol       Date:  2013-09-14       Impact factor: 3.422

4.  Neutrophils influx and proinflammatory cytokines inhibition by sodium salicylate, unlike aspirin, in Candida albicans-induced peritonitis model.

Authors:  Priscilla Aparecida Tártari Pereira; Daniel Bini; Fernanda Bovo; Lucia Helena Faccioli; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2016-01-13       Impact factor: 2.099

Review 5.  Arachidonic acid metabolites in pathogenic yeasts.

Authors:  Ruan Ells; Johan Lf Kock; Jacobus Albertyn; Carolina H Pohl
Journal:  Lipids Health Dis       Date:  2012-08-08       Impact factor: 3.876

6.  Anti-Candida properties of asaronaldehyde of Acorus gramineus rhizome and three structural isomers.

Authors:  Sandeep B Rajput; Ravikumar B Shinde; Madhushree M Routh; Sankunny M Karuppayil
Journal:  Chin Med       Date:  2013-09-08       Impact factor: 5.455

7.  A comparison between characterization and biological properties of Brazilian fresh and aged propolis.

Authors:  Eduardo Morgado Schmidt; Daniele Stock; Fabio José Garcia Chada; Daiane Finger; Alexandra Christine Helena Frankland Sawaya; Marcos Nogueira Eberlin; Maria Lurdes Felsner; Sueli Pércio Quináia; Marta Chagas Monteiro; Yohandra Reyes Torres
Journal:  Biomed Res Int       Date:  2014-11-03       Impact factor: 3.411

Review 8.  Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A Review.

Authors:  Xinning Liu; Decai Wang; Cuixiang Yu; Tao Li; Jianqiao Liu; Shujuan Sun
Journal:  Front Microbiol       Date:  2016-12-06       Impact factor: 5.640

9.  Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.

Authors:  Francisco Madariaga-Venegas; Roberto Fernández-Soto; Luisa Fernanda Duarte; Nicole Suarez; Daniela Delgadillo; José A Jara; Ricardo Fernández-Ramires; Blanca Urzúa; Alfredo Molina-Berríos
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

10.  Comparative Study of Chemical Composition and Biological Activity of Yellow, Green, Brown, and Red Brazilian Propolis.

Authors:  Christiane Schineider Machado; João Benhur Mokochinski; Tatiana Onofre de Lira; Fátima de Cassia Evangelista de Oliveira; Magda Vieira Cardoso; Roseane Guimarães Ferreira; Alexandra Christine Helena Frankland Sawaya; Antonio Gilberto Ferreira; Cláudia Pessoa; Osmany Cuesta-Rubio; Marta Chagas Monteiro; Mônica Soares de Campos; Yohandra Reyes Torres
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-21       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.